PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 16751249-2 2006 Freely diffusing Tb3+ -chelates of varying charge constituted a set of energy transfer donors to the acceptor, crystal violet, a noncompetitive antagonist of the nAChR. Gentian Violet 111-125 cholinergic receptor nicotinic alpha 4 subunit Homo sapiens 162-167 16751249-3 2006 Energy transfer from a neutral Tb3+ -chelate to nAChR-bound crystal violet was reduced 95% relative to the energy transfer to free crystal violet. Gentian Violet 60-74 cholinergic receptor nicotinic alpha 4 subunit Homo sapiens 48-53 16751249-3 2006 Energy transfer from a neutral Tb3+ -chelate to nAChR-bound crystal violet was reduced 95% relative to the energy transfer to free crystal violet. Gentian Violet 131-145 cholinergic receptor nicotinic alpha 4 subunit Homo sapiens 48-53 16751249-4 2006 This result indicated that crystal violet was strongly shielded from solvent when bound to the nAChR. Gentian Violet 27-41 cholinergic receptor nicotinic alpha 4 subunit Homo sapiens 95-100 34969831-6 2022 To explore if the different analogs could affect the nAChR conformational state, the nAChR conformational-sensitive probe crystal violet (CrV) was used. Gentian Violet 122-136 cholinergic receptor nicotinic alpha 4 subunit Homo sapiens 53-58 34969831-6 2022 To explore if the different analogs could affect the nAChR conformational state, the nAChR conformational-sensitive probe crystal violet (CrV) was used. Gentian Violet 122-136 cholinergic receptor nicotinic alpha 4 subunit Homo sapiens 85-90 34969831-6 2022 To explore if the different analogs could affect the nAChR conformational state, the nAChR conformational-sensitive probe crystal violet (CrV) was used. Gentian Violet 138-141 cholinergic receptor nicotinic alpha 4 subunit Homo sapiens 53-58 34969831-6 2022 To explore if the different analogs could affect the nAChR conformational state, the nAChR conformational-sensitive probe crystal violet (CrV) was used. Gentian Violet 138-141 cholinergic receptor nicotinic alpha 4 subunit Homo sapiens 85-90